New therapy targets cause of adult-onset muscular dystrophy by Staff April 1, 2019 April 1, 2019 19 views 19The compound called Cugamycin works by recognizing toxic RNA repeats and destroying the garbled gene transcript.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post New polymer mixture creates ultra-sensitive heat sensor next post How the brain fights off fears that return to haunt us Related Posts Enzyme-inspired catalyst puts chemicals in right position to... September 12, 2024 Discovery could lead to longer-lasting EV batteries, hasten... September 12, 2024 New discovery about ice layer formation in ice... September 12, 2024 New study reveals food waste bans ineffective in... September 12, 2024 How El Nino and mega ocean warming caused... September 12, 2024 Supported youth become supportive adults, researchers find September 12, 2024